As of 2025-07-19, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 134.53 USD. This relative valuation is based on P/E multiples. With the latest stock price at 47.63 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is 182.4%.
The range of the Relative Valuation is 99.82 - 181.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.2x | 20.0x |
| Forward P/E multiples | 13.3x - 19.4x | 15.8x |
| Fair Price | 99.82 - 181.77 | 134.53 |
| Upside | 109.6% - 281.6% | 182.4% |
| Date | P/E |
| 2025-07-11 | 6.47 |
| 2025-07-10 | 6.60 |
| 2025-07-09 | 6.49 |
| 2025-07-08 | 6.35 |
| 2025-07-07 | 6.39 |
| 2025-07-03 | 6.54 |
| 2025-07-02 | 6.55 |
| 2025-07-01 | 6.47 |
| 2025-06-30 | 6.51 |
| 2025-06-27 | 6.64 |
| 2025-06-26 | 6.60 |
| 2025-06-25 | 6.51 |
| 2025-06-24 | 6.61 |
| 2025-06-23 | 6.61 |
| 2025-06-20 | 6.69 |
| 2025-06-18 | 6.72 |
| 2025-06-17 | 6.78 |
| 2025-06-16 | 6.91 |
| 2025-06-13 | 6.83 |
| 2025-06-12 | 6.79 |
| 2025-06-11 | 6.77 |
| 2025-06-10 | 6.89 |
| 2025-06-09 | 6.89 |
| 2025-06-06 | 6.95 |
| 2025-06-05 | 6.89 |
| 2025-06-04 | 6.81 |
| 2025-06-03 | 6.75 |
| 2025-06-02 | 6.51 |
| 2025-05-30 | 6.47 |
| 2025-05-29 | 6.51 |
| 2025-05-28 | 6.30 |
| 2025-05-27 | 6.38 |
| 2025-05-23 | 6.12 |
| 2025-05-22 | 6.07 |
| 2025-05-21 | 6.16 |
| 2025-05-20 | 6.29 |
| 2025-05-19 | 6.26 |
| 2025-05-16 | 6.13 |
| 2025-05-15 | 6.04 |
| 2025-05-14 | 6.23 |
| 2025-05-13 | 6.18 |
| 2025-05-12 | 6.13 |
| 2025-05-09 | 5.89 |
| 2025-05-08 | 5.66 |
| 2025-05-07 | 5.43 |
| 2025-05-06 | 4.82 |
| 2025-05-05 | 5.42 |
| 2025-05-02 | 6.66 |
| 2025-05-01 | 6.60 |
| 2025-04-30 | 6.64 |